Compositions and methods for treating CNS disorders
US7598265B2 · kind B2 · utility
3Cited by
32References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 10, 2005 |
| Grant date | Oct 6, 2009 |
| Priority date | — |
| Expiry date | Sep 5, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention generally relates to thienopyridinone 5-HT4 receptor modulators, and in particular the use of these compounds and their pharmaceutical compositions, e.g., in the treatment, modulation and/or prevention of physiological conditions associated with serotonin action, such as in treating Alzheimer's disease, cognition disorders, depression, and anxiety.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.